{"grounding": "Rather than serving as a mere onlooker, adipose tissue is a complex endocrine organ and active participant in disease initiation and progression. Disruptions of biological processes operating within adipose can disturb healthy systemic physiology, the sequelae of which include metabolic disorders such as obesity and type 2 diabetes. A burgeoning interest in the field of adipose research has allowed for the elucidation of regulatory networks underlying both adipose tissue function and dysfunction. Despite this progress, few diseases are treated by targeting maladaptation in the adipose, an oft-overlooked organ. In this review, we elaborate on the distinct subtypes of adipocytes, their developmental origins and secretory roles, and the dynamic interplay at work within the tissue itself. Central to this discussion is the relationship between adipose and disease states, including obesity, cachexia, and infectious diseases, as we aim to leverage our wealth of knowledge for the development of novel and targeted therapeutics.", "generated_text": "Adipose tissue remodeling plays a pivotal role in various pathophysiological conditions, including burns, infectious diseases, and cachexia. The process of browning, where white adipose tissue (WAT) is converted into brown adipose tissue (BAT), has been implicated in the regulation of energy metabolism and inflammation. However, excessive or dysregulated browning can contribute to fibrosis and tissue damage. In the context of burns, infectious diseases, and cachexia, adipose tissue remodeling is characterized by the infiltration of immune cells, the release of pro-inflammatory cytokines, and the formation of fibrotic tissue. This review aims to summarize the current understanding of adipose tissue remodeling in these conditions, highlighting the complex interplay between browning, fibrosis, and inflammation. The findings of this review have significant implications for the development of novel therapeutic strategies targeting adipose tissue remodeling in these diseases, with the ultimate goal of improving patient outcomes and reducing morbidity and mortality.", "label": 1}